1 not yet recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Not yet recruiting 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Refractory Diffuse Large B-cell Lymphoma: new trials by email Literature Review of Refractory Diffuse Large B-cell Lymphoma trials Research Report on Refractory Diffuse Large B-cell Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase I/II Study of Diffuse Large B-cell Lymphoma Rituximab Paclitaxel Ruxolitinib - Refractory Diffuse Large B-cell Lymphoma | Phase 1 / Phase 2 | Not yet recruiting | National Health Research Institutes, Taiwan | 74 | 2021-05-01 | 2021-04-23 |
Lymphoma, Large B-Cell, Diffuse (1)
Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoma (1) · Lymphoma, B-Cell (1) · Lymphoma, Non-Hodgkin (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1)